Translational Neurodegeneration

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy

Current progress of mitochondrial transplantation that promotes neuronal regeneration

Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy

Parkinson’s disease in China: a forty-year growing track of bedside work

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

Microbiome changes: an indicator of Parkinson’s disease?

Targeting γ-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models

Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in

Longitudinal diffusion tensor magnetic resonance imaging analysis at the cohort level reveals disturbed cortical and callosal microstructure with spared corticospinal tract in the TDP-43G298S ALS mouse model

A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease

Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy

Cognitive decline is related to high blood glucose levels in older Chinese adults with the ApoE ε3/ε3 genotype

Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease

DNA repair deficiency in neuropathogenesis: when all roads lead to mitochondria

Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1–40 and cerebral vulnerability in normal aging

Xenografting of human umbilical mesenchymal stem cells from Wharton’s jelly ameliorates mouse spinocerebellar ataxia type 1

NF-κB/c-Rel deficiency causes Parkinson’s disease-like prodromal symptoms and progressive pathology in mice

Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia

Enriched gestation activates the IGF pathway to evoke embryo-adult benefits to prevent Alzheimer’s disease

Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration

Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 pathway in Tg2576 mice

Clinicopathologic characterization and abnormal autophagy of CSF1R-related leukoencephalopathy

Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease

Transplantation of bone marrow derived macrophages reduces markers of neuropathology in an APP/PS1 mouse model

How to spot ocular abnormalities in progressive supranuclear palsy? A practical review

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET

Correction to: Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history